Medicine and Health
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
A. L. Koen, A. Izu, et al.
Discover the latest findings on COVID-19 vaccine efficacy against distinct SARS-CoV-2 variants from the comprehensive COV005 study conducted by renowned researchers. This double-blind, randomized trial sheds light on the safety and effectiveness of the AZD1222 vaccine in South African adults across different waves of infection.
Related Publications
Explore these studies to deepen your understanding of the subject.

